761 related articles for article (PubMed ID: 7613276)
21. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
[TBL] [Abstract][Full Text] [Related]
22. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
23. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.
Williams JW; Mulrow CD; Chiquette E; Noël PH; Aguilar C; Cornell J
Ann Intern Med; 2000 May; 132(9):743-56. PubMed ID: 10787370
[TBL] [Abstract][Full Text] [Related]
24. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.
Trindade E; Menon D; Topfer LA; Coloma C
CMAJ; 1998 Nov; 159(10):1245-52. PubMed ID: 9861221
[TBL] [Abstract][Full Text] [Related]
25. Antidepressants and the risk of falls among nursing home residents.
Thapa PB; Gideon P; Cost TW; Milam AB; Ray WA
N Engl J Med; 1998 Sep; 339(13):875-82. PubMed ID: 9744971
[TBL] [Abstract][Full Text] [Related]
26. [Mirtazapine versus other antidepressive agents for depression].
Knud Larsen J
Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial.
Kendrick T; Peveler R; Longworth L; Baldwin D; Moore M; Chatwin J; Thornett A; Goddard J; Campbell M; Smith H; Buxton M; Thompson C
Br J Psychiatry; 2006 Apr; 188():337-45. PubMed ID: 16582060
[TBL] [Abstract][Full Text] [Related]
28. Amitriptyline for depression.
Guaiana G; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2007 Jul; (3):CD004186. PubMed ID: 17636748
[TBL] [Abstract][Full Text] [Related]
29. Economic outcomes associated with tricyclic antidepressant and selective serotonin reuptake inhibitor treatments for depression.
Crown WH
Acta Psychiatr Scand Suppl; 2000; 403():62-6. PubMed ID: 11019937
[TBL] [Abstract][Full Text] [Related]
30. Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide.
Freemantle N; House A; Song F; Mason JM; Sheldon TA
BMJ; 1994 Jul; 309(6949):249-53. PubMed ID: 7832842
[TBL] [Abstract][Full Text] [Related]
31. Treatment of severe depression with the selective serotonin reuptake inhibitors.
Schatzberg AF
Depress Anxiety; 1996-1997; 4(4):182-9. PubMed ID: 9166650
[TBL] [Abstract][Full Text] [Related]
32. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.
Peet M
Br J Psychiatry; 1994 Apr; 164(4):549-50. PubMed ID: 8038948
[TBL] [Abstract][Full Text] [Related]
33. An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts.
Berndt ER; Bhattacharjya A; Mishol DN; Arcelus A; Lasky T
J Ment Health Policy Econ; 2002 Mar; 5(1):3-19. PubMed ID: 12529566
[TBL] [Abstract][Full Text] [Related]
34. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
[TBL] [Abstract][Full Text] [Related]
35. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
[TBL] [Abstract][Full Text] [Related]
36. Tricyclic antidepressants and headaches: systematic review and meta-analysis.
Jackson JL; Shimeall W; Sessums L; Dezee KJ; Becher D; Diemer M; Berbano E; O'Malley PG
BMJ; 2010 Oct; 341():c5222. PubMed ID: 20961988
[TBL] [Abstract][Full Text] [Related]
37. Effects of antidepressant treatments on health service utilization and medical costs among patients with depression: a nationwide population-based retrospective cohort study in Taiwan.
Su KP; Tang CH; Chang HC; Chiu WC; Lu N; Huang KC
Int Clin Psychopharmacol; 2019 Jul; 34(4):170-178. PubMed ID: 30964763
[TBL] [Abstract][Full Text] [Related]
38. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
Taylor D
Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological interventions for somatoform disorders in adults.
Kleinstäuber M; Witthöft M; Steffanowski A; van Marwijk H; Hiller W; Lambert MJ
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010628. PubMed ID: 25379990
[TBL] [Abstract][Full Text] [Related]
40. Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials.
Barbui C; Hotopf M
Br J Psychiatry; 2001 Feb; 178():129-44. PubMed ID: 11157426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
